MECHANISM OF ACTION OF 4-AMINOPYRIDINE IN THE SYMPTOMATIC TREATMENT OF MULTIPLE-SCLEROSIS

被引：16
|
作者：
DAVIS, FA [1 ]
STEFOSKI, D [1 ]
QUANDT, FN [1 ]
机构：
[1] RUSH UNIV,DEPT PHYSIOL,CHICAGO,IL 60612
来源：
ANNALS OF NEUROLOGY | 1995年 / 37卷 / 05期
关键词：
D O I：
10.1002/ana.410370524
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：684 / 684
页数：1
相关论文
共 50 条
  • [1] 4-AMINOPYRIDINE IN MULTIPLE-SCLEROSIS
    POLMAN, CH
    VANDIEMEN, HAM
    VANDONGEN, MMMM
    KOETSIER, JC
    VANLOENEN, AC
    VANWALBEEK, HK
    ANNALS OF NEUROLOGY, 1990, 28 (04) : 589 - 589
  • [2] 4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review
    Jensen, Henrik Boye
    Ravnborg, Mads
    Dalgas, Ulrik
    Stenager, Egon
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2014, 7 (02) : 97 - 113
  • [3] 4-AMINOPYRIDINE IN MULTIPLE-SCLEROSIS - PROLONGED ADMINISTRATION
    STEFOSKI, D
    DAVIS, FA
    FITZSIMMONS, WE
    LUSKIN, SS
    RUSH, J
    PARKHURST, GW
    NEUROLOGY, 1991, 41 (09) : 1344 - 1348
  • [4] EFFECTS OF 4-AMINOPYRIDINE IN PATIENTS WITH MULTIPLE-SCLEROSIS
    JONES, RE
    HERON, JR
    FOSTER, DH
    SNELGAR, RS
    MASON, RJ
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1983, 60 (03) : 353 - 362
  • [5] 4-Aminopyridine (Fampridine) : A new attempt for the symptomatic treatment of multiple sclerosis
    Husseini L.
    Leussink V.I.
    Kieseier B.C.
    Hartung H.-P.
    Der Nervenarzt, 2010, 81 (2) : 203 - 211
  • [6] 4-AMINOPYRIDINE IMPROVES CLINICAL SIGNS IN MULTIPLE-SCLEROSIS
    STEFOSKI, D
    DAVIS, FA
    FAUT, M
    SCHAUF, CL
    ANNALS OF NEUROLOGY, 1987, 21 (01) : 71 - 77
  • [7] 4-AMINOPYRIDINE IMPROVES CLINICAL SIGNS IN MULTIPLE-SCLEROSIS
    STEFOSKI, D
    DAVIS, FA
    TYSZKA, MF
    SCHAUF, CL
    ANNALS OF NEUROLOGY, 1985, 18 (01) : 131 - 131
  • [8] Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis
    Schwid, SR
    Petrie, MD
    McDermott, MP
    Tierney, DS
    Mason, DH
    Goodman, AD
    NEUROLOGY, 1997, 48 (04) : 817 - 821
  • [9] A COMPARISON BETWEEN 4-AMINOPYRIDINE AND 3,4-DIAMINOPYRIDINE IN THE TREATMENT OF MULTIPLE-SCLEROSIS
    BERTELSMANN, FW
    POLMAN, CH
    VANDIEMEN, HAM
    DEWAAL, R
    KOETSIER, JC
    ANNALS OF NEUROLOGY, 1992, 32 (02) : 256 - 256
  • [10] 4-AMINOPYRIDINE IN THE TREATMENT OF PATIENTS WITH MULTIPLE-SCLEROSIS - LONG-TERM EFFICACY AND SAFETY
    POLMAN, CH
    BERTELSMANN, FW
    VANLOENEN, AC
    KOETSIER, JC
    ARCHIVES OF NEUROLOGY, 1994, 51 (03) : 292 - 296
12345